R&D Systems™ Recombinant Mouse Lymphotoxin alpha1/beta2 Protein

Catalog No.	Quantity
99-68LY-025	25 μg

Catalog No. 99-68LY-025 Supplier R&D Systems™ Supplier No. 9968LY025

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Mouse Lymphotoxin alpha1/beta2 Protein is derived from NS0. The Recombinant Mouse Lymphotoxin alpha1/beta2 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P09225 (rmLT alpha); P41155 (rmLT beta)
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
• Gene ID (Entrez): 4049
• Molecular Weight (g/mol): 50 kDa
• Quantity: 25 μg
• Source: Mouse myeloma cell line,NS0-derived mouse Lymphotoxin protein Mouse LT alpha (Lys59-Leu202) Accession &Num; P09225 GGGGS Mouse LT beta (Leu153-Gly306) Accession &Num; P41155 GGGGS Mouse LT beta (Leu153-Gly306) Accession &Num; P41155
• Storage Requirements: 12 months from date of receipt, ≤ -20°C as supplied; 1 month, 2 to 8°C under sterile conditions after reconstitution; 3 months, ≤ -20°C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Cross Reactivity: Lymphotoxin
• Species: Mouse
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.